Cycle Pharmaceuticals, Inc. (Cycle) announces today completion of the acquisition of Banner Life Sciences, LLC (Banner) which includes its BAFIERTAM ® (monomethyl fumarate) product for the treatment ...

Purpose: Data collected from the Food and Drug Administration (FDA) under the Freedom of Information Act are presented to help clinicians understand the data prompting the black-box warning for ...

Patients who underwent revascularization procedures were divided into two groups based on subsequent antithrombotic therapy: (1) aspirin plus rivaroxaban 2.5 mg/bid; (2 ... 95% CI: 0.24–0.85), but no ...

From 1979-85, 2435 patients with a transient ischaemic attack or minor ischaemic stroke were randomly allocated to receive long term "blind" treatment with aspirin 600 mg twice daily (n = 815), ...

This constituted aspirin (81 mg daily per day) in addition to one of either ... The robotic intracranial intervention was on average 85±15 min from when the microcatheter was first connected to when ...

Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...

A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...

For decades, taking low-dose aspirin every day was widely recommended as an easy way to prevent heart attacks and strokes. But that advice has changed.

People without the risk of heart problems who consumed daily low-dose aspirin, it increased the chance of bleeding in the ...

She had begun taking low-dose aspirin at 13 weeks’ gestation to decrease the risk of preeclampsia associated with antepartum obesity. She had no history of hypertension before or during pregnancy.

Safe aspirin elimination in patients with HeartMate 3 LVAD reduces bleeding risk, offering key clinical practice insights.

ACS: Acute coronary syndrome; CV: Cardiovascular; MI: Myocardial infarction; PCI: Percutaneous coronary intervention; TIA: Transient ischemic attack.